Cowen downgraded Axovant Sciences (NASDAQ: AXON) from Outperform to Market Perform.Analyst Ritu Baral commented, "AXON announced failure of the Ph2/3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE